Johnson & Johnson wins EU approval for new gMG treatment

4th December 2025 Uncategorised 0

Nipocalimab authorised for adults with antibody-positive generalised myasthenia gravis

More: Johnson & Johnson wins EU approval for new gMG treatment
Source: News